Drug Profile
PHN 121
Alternative Names: PHN-121Latest Information Update: 22 Sep 2015
Price :
$50
*
At a glance
- Originator Industrial Technology Research Institute
- Developer PhytoHealth
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 29 Nov 2013 PhytoHealth terminates a phase I/II ENCHAMP trial in Hepatitis C in Taiwan (NCT01052090)
- 22 Oct 2008 Phase-I clinical trials in Hepatitis C treatment in Taiwan (unspecified route)